Virtual Reality for Pain and Anxiety Relief During Peripheral Angioplasty

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Peripheral AngioplastyPain ManagementVirtual Reality
Interventions
OTHER

Virtual Reality

Virtual reality (VR) will be applied to patients in this group in addition to painkillers. VR is a non-pharmacological method that uses special glasses to create an immersive visual and auditory experience. It helps distract patients from the procedure and may reduce pain and anxiety.

DRUG

dexketoprofen + midazolam

Patients in this group will be treated with dexketoprofen as a painkiller and midazolam as an anxiolytic, if needed. This combination aims to reduce both pain and anxiety during the procedure.

Trial Locations (1)

37200

Kastamonu Education and Research Hospital, Kastamonu

All Listed Sponsors
lead

Kastamonu University

OTHER

NCT07057752 - Virtual Reality for Pain and Anxiety Relief During Peripheral Angioplasty | Biotech Hunter | Biotech Hunter